vs

Side-by-side financial comparison of MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) and Northfield Bancorp, Inc. (NFBK). Click either name above to swap in a different company.

MARAVAI LIFESCIENCES HOLDINGS, INC. is the larger business by last-quarter revenue ($49.9M vs $41.3M, roughly 1.2× Northfield Bancorp, Inc.). MARAVAI LIFESCIENCES HOLDINGS, INC. runs the higher net margin — -71.6% vs -1545.5%, a 1474.0% gap on every dollar of revenue. On growth, Northfield Bancorp, Inc. posted the faster year-over-year revenue change (12.7% vs -11.8%). Northfield Bancorp, Inc. produced more free cash flow last quarter ($52.5M vs $-24.9M). Over the past eight quarters, Northfield Bancorp, Inc.'s revenue compounded faster (15.0% CAGR vs -11.9%).

Maravai LifeSciences Holdings is a global life sciences firm developing critical reagents, diagnostic products, and tech solutions to support biopharma research, drug development, clinical diagnostics, and cell/gene therapy manufacturing. It serves biotech, pharma, research bodies and labs worldwide across three core segments.

Northfield Bancorp, Inc. is a regional bank holding company based in the United States, operating primarily across the U.S. Northeast region. It provides a full range of personal and commercial banking services including deposit accounts, mortgage loans, commercial lending, and wealth management solutions for retail consumers, small to medium-sized businesses and local community clients.

MRVI vs NFBK — Head-to-Head

Bigger by revenue
MRVI
MRVI
1.2× larger
MRVI
$49.9M
$41.3M
NFBK
Growing faster (revenue YoY)
NFBK
NFBK
+24.5% gap
NFBK
12.7%
-11.8%
MRVI
Higher net margin
MRVI
MRVI
1474.0% more per $
MRVI
-71.6%
-1545.5%
NFBK
More free cash flow
NFBK
NFBK
$77.4M more FCF
NFBK
$52.5M
$-24.9M
MRVI
Faster 2-yr revenue CAGR
NFBK
NFBK
Annualised
NFBK
15.0%
-11.9%
MRVI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MRVI
MRVI
NFBK
NFBK
Revenue
$49.9M
$41.3M
Net Profit
$-35.7M
$-27.4M
Gross Margin
25.8%
Operating Margin
-117.9%
-1263.3%
Net Margin
-71.6%
-1545.5%
Revenue YoY
-11.8%
12.7%
Net Profit YoY
-37.7%
-343.6%
EPS (diluted)
$-0.24
$-0.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MRVI
MRVI
NFBK
NFBK
Q4 25
$49.9M
$41.3M
Q3 25
$41.6M
$39.2M
Q2 25
$47.4M
$38.9M
Q1 25
$46.9M
$34.8M
Q4 24
$56.6M
$36.7M
Q3 24
$69.0M
$31.8M
Q2 24
$69.4M
$31.5M
Q1 24
$64.2M
$31.3M
Net Profit
MRVI
MRVI
NFBK
NFBK
Q4 25
$-35.7M
$-27.4M
Q3 25
$-25.6M
$10.8M
Q2 25
$-39.6M
$9.6M
Q1 25
$-29.9M
$7.9M
Q4 24
$-25.9M
$11.3M
Q3 24
$-97.1M
$6.5M
Q2 24
$-9.8M
$6.0M
Q1 24
$-12.1M
$6.2M
Gross Margin
MRVI
MRVI
NFBK
NFBK
Q4 25
25.8%
Q3 25
13.6%
Q2 25
16.4%
Q1 25
16.5%
Q4 24
34.3%
Q3 24
46.7%
Q2 24
44.4%
Q1 24
40.3%
Operating Margin
MRVI
MRVI
NFBK
NFBK
Q4 25
-117.9%
-1263.3%
Q3 25
-98.6%
37.7%
Q2 25
-139.8%
35.6%
Q1 25
-104.9%
31.0%
Q4 24
-66.7%
38.0%
Q3 24
-239.9%
27.9%
Q2 24
-19.4%
29.1%
Q1 24
-29.4%
27.2%
Net Margin
MRVI
MRVI
NFBK
NFBK
Q4 25
-71.6%
-1545.5%
Q3 25
-61.4%
27.4%
Q2 25
-83.5%
24.6%
Q1 25
-63.9%
22.6%
Q4 24
-45.8%
30.7%
Q3 24
-140.6%
20.5%
Q2 24
-14.1%
18.9%
Q1 24
-18.8%
19.9%
EPS (diluted)
MRVI
MRVI
NFBK
NFBK
Q4 25
$-0.24
$-0.68
Q3 25
$-0.18
$0.27
Q2 25
$-0.27
$0.24
Q1 25
$-0.21
$0.19
Q4 24
$-0.21
$0.27
Q3 24
$-0.68
$0.16
Q2 24
$-0.07
$0.14
Q1 24
$-0.09
$0.15

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MRVI
MRVI
NFBK
NFBK
Cash + ST InvestmentsLiquidity on hand
$216.9M
$164.0M
Total DebtLower is stronger
$291.8M
Stockholders' EquityBook value
$212.4M
$690.1M
Total Assets
$770.6M
$5.8B
Debt / EquityLower = less leverage
1.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MRVI
MRVI
NFBK
NFBK
Q4 25
$216.9M
$164.0M
Q3 25
$243.6M
$131.7M
Q2 25
$269.9M
$97.6M
Q1 25
$285.1M
$101.7M
Q4 24
$322.4M
$167.7M
Q3 24
$578.2M
$232.9M
Q2 24
$573.2M
$153.5M
Q1 24
$561.7M
$238.8M
Total Debt
MRVI
MRVI
NFBK
NFBK
Q4 25
$291.8M
Q3 25
$292.8M
Q2 25
$293.9M
Q1 25
$294.9M
Q4 24
$295.9M
$666.4M
Q3 24
$521.7M
Q2 24
$522.5M
Q1 24
$523.3M
Stockholders' Equity
MRVI
MRVI
NFBK
NFBK
Q4 25
$212.4M
$690.1M
Q3 25
$245.4M
$719.6M
Q2 25
$265.9M
$710.3M
Q1 25
$300.6M
$711.1M
Q4 24
$325.3M
$704.7M
Q3 24
$344.9M
$699.6M
Q2 24
$434.7M
$693.0M
Q1 24
$410.7M
$698.4M
Total Assets
MRVI
MRVI
NFBK
NFBK
Q4 25
$770.6M
$5.8B
Q3 25
$849.2M
$5.7B
Q2 25
$897.0M
$5.7B
Q1 25
$959.8M
$5.7B
Q4 24
$1.0B
$5.7B
Q3 24
$1.3B
$5.7B
Q2 24
$1.4B
$5.7B
Q1 24
$1.4B
$5.9B
Debt / Equity
MRVI
MRVI
NFBK
NFBK
Q4 25
1.37×
Q3 25
1.19×
Q2 25
1.11×
Q1 25
0.98×
Q4 24
0.91×
0.95×
Q3 24
1.51×
Q2 24
1.20×
Q1 24
1.27×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MRVI
MRVI
NFBK
NFBK
Operating Cash FlowLast quarter
$-22.8M
$53.7M
Free Cash FlowOCF − Capex
$-24.9M
$52.5M
FCF MarginFCF / Revenue
-49.9%
127.1%
Capex IntensityCapex / Revenue
4.2%
2.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-70.7M
$89.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MRVI
MRVI
NFBK
NFBK
Q4 25
$-22.8M
$53.7M
Q3 25
$-15.2M
$13.9M
Q2 25
$-10.3M
$14.1M
Q1 25
$-9.4M
$9.4M
Q4 24
$-14.6M
$31.1M
Q3 24
$13.1M
$14.0M
Q2 24
$17.4M
$6.9M
Q1 24
$-8.5M
$4.2M
Free Cash Flow
MRVI
MRVI
NFBK
NFBK
Q4 25
$-24.9M
$52.5M
Q3 25
$-18.1M
$13.6M
Q2 25
$-13.1M
$13.9M
Q1 25
$-14.6M
$9.2M
Q4 24
$-20.5M
$30.0M
Q3 24
$4.5M
$13.7M
Q2 24
$7.9M
$6.7M
Q1 24
$-14.1M
$3.8M
FCF Margin
MRVI
MRVI
NFBK
NFBK
Q4 25
-49.9%
127.1%
Q3 25
-43.4%
34.6%
Q2 25
-27.7%
35.7%
Q1 25
-31.2%
26.3%
Q4 24
-36.2%
81.6%
Q3 24
6.6%
43.2%
Q2 24
11.4%
21.1%
Q1 24
-22.0%
12.1%
Capex Intensity
MRVI
MRVI
NFBK
NFBK
Q4 25
4.2%
2.8%
Q3 25
7.0%
0.8%
Q2 25
6.1%
0.6%
Q1 25
11.2%
0.7%
Q4 24
10.3%
3.1%
Q3 24
12.4%
0.7%
Q2 24
13.8%
0.8%
Q1 24
8.8%
1.4%
Cash Conversion
MRVI
MRVI
NFBK
NFBK
Q4 25
Q3 25
1.29×
Q2 25
1.48×
Q1 25
1.20×
Q4 24
2.76×
Q3 24
2.14×
Q2 24
1.16×
Q1 24
0.68×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MRVI
MRVI

Cygnus Segment$27.2M54%
Other$18.4M37%
Shipping And Handling$4.3M9%

NFBK
NFBK

Segment breakdown not available.

Related Comparisons